Target Name: CEP68
NCBI ID: G23177
Review Report on CEP68 Target / Biomarker Content of Review Report on CEP68 Target / Biomarker
CEP68
Other Name(s): KIAA0582 | Centrosomal protein 68kDa | CEP68_HUMAN | Centrosomal protein of 68 kDa | centrosomal protein 68 | Centrosomal protein 68, transcript variant 1 | Cep68 | centrosomal protein 68kDa | Centrosomal protein of 68 kDa (isoform a) | CEP68 variant 1

CEP68 Regulates Cytoskeleton and CAPZ Protein in Tissues

CEP68 (KIAA0582) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. Its full name is cytoskeletal protein 68, and it is a member of the KIAA class of proteins that are involved in cell signaling.

One of the functions of CEP68 is to regulate the distribution of chloride ions in and out of cells. Chloride ions are important for a variety of physiological processes, including muscle contractions, nerve signaling, and cell signaling. They also play a role in maintaining the stability of the cell membrane and the intracellular fluid.

CEP68 is also involved in the regulation of the cytoskeleton, which is the structure that gives cells their shape and supports their mechanical forces. The cytoskeleton is made up of a complex network of proteins that help to keep cells in a stable shape and maintain their structural integrity.

One of the ways that CEP68 is involved in the regulation of the cytoskeleton is through its role in the regulation of the cytoskeleton-associated protein (CAP) complex. CAP is a protein that is involved in the regulation of the cytoskeleton and is composed of a protein called CAPZ (KiAA0783) and several other proteins.

CEP68 is one of the proteins that is associated with the CAPZ protein. It helps to regulate the formation and stability of the CAPZ protein and is involved in the regulation of the cytoskeleton-associated protein (CAP) complex. This complex is responsible for maintaining the structural integrity of the cytoskeleton and is involved in a variety of cellular processes, including cell signaling and the regulation of ion channels.

In addition to its role in the regulation of the CAPZ protein, CEP68 is also involved in the regulation of the cytoskeleton in other ways. For example, it is involved in the regulation of the cytoskeleton-associated protein (CAP) kinase (KAPK2), which is a protein that is involved in the regulation of the cytoskeleton and is composed of the protein KAPK2 and several other proteins.

CEP68 is also involved in the regulation of the cytoskeleton in the regulation of the cytoskeleton-associated protein (CAP) complex. This complex is made up of the proteins CAPZ, KAPK2, and other proteins and is responsible for maintaining the structural integrity of the cytoskeleton.

In conclusion, CEP68 is a protein that is involved in the regulation of various cellular processes, including the regulation of the cytoskeleton and the regulation of the CAPZ protein. It is also involved in the regulation of the CAPK2 protein and the CAPZ protein itself. These proteins play important roles in the regulation of the cytoskeleton and are potential drug targets or biomarkers for a variety of diseases.

Protein Name: Centrosomal Protein 68

Functions: Involved in maintenance of centrosome cohesion, probably as part of a linker structure which prevents centrosome splitting (PubMed:18042621). Required for localization of CDK5RAP2 to the centrosome during interphase (PubMed:24554434, PubMed:25503564). Contributes to CROCC/rootletin filament formation (PubMed:30404835)

The "CEP68 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CEP68 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

CEP70 | CEP72 | CEP72-DT | CEP76 | CEP78 | CEP83 | CEP83-DT | CEP85 | CEP85L | CEP89 | CEP95 | CEP97 | CEPT1 | CER1 | Ceramidase | Ceramide synthase | CERCAM | CERK | CERKL | CERNA2 | CERS1 | CERS2 | CERS3 | CERS3-AS1 | CERS4 | CERS5 | CERS6 | CERS6-AS1 | CERT1 | CES1 | CES1P1 | CES1P2 | CES2 | CES3 | CES4A | CES5A | CETN1 | CETN2 | CETN3 | CETN4P | CETP | CFAP100 | CFAP100-DT | CFAP107 | CFAP119 | CFAP126 | CFAP141 | CFAP157 | CFAP161 | CFAP20 | CFAP206 | CFAP20DC | CFAP20DC-AS1 | CFAP20DC-DT | CFAP210 | CFAP221 | CFAP251 | CFAP276 | CFAP298 | CFAP299 | CFAP300 | CFAP36 | CFAP410 | CFAP418 | CFAP418-AS1 | CFAP43 | CFAP44 | CFAP44-AS1 | CFAP45 | CFAP46 | CFAP47 | CFAP52 | CFAP53 | CFAP54 | CFAP57 | CFAP58 | CFAP61 | CFAP65 | CFAP68 | CFAP69 | CFAP70 | CFAP73 | CFAP74 | CFAP77 | CFAP90 | CFAP91 | CFAP92 | CFAP95 | CFAP95-DT | CFAP97 | CFAP97D1 | CFAP99 | CFB | CFC1 | CFD | CFDP1 | CFH | CFHR1 | CFHR2 | CFHR3